FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frankie Holmes

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Drug Evaluation

Co-author Network

Publications

TOP 3
Libero Santarpia; Katherine Stemke-Hale; W Fraser Symmans; Vicente Valero; Tatiana Vidaurre; Bailiang Wang; Elliana J Young; Yuan Qi; Daniel J Booser; Giulia Bottai; Angelo Di Leo; Henry Gomez; Ana M Gonzalez-Angulo; Beth Hellerstedt; Frankie A Holmes; Gabriel N Hortobagyi; Joyce O'Shaughnessy; John Pippen; Lajos Pusztai
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.
Takayuki Iwamoto; Giampaolo Bianchini; Daniel J Booser; Yuan Qi; Charles Coutant; Christine Ya-Hui Shiang; Libero Santarpia; Junji Matsuoka; Gabriel N Hortobagyi; W Fraser Symmans; Frankie A Holmes; Joyce A O'Shaughnessy; Beth Hellerstedt; John Pippen; Fabrice Andre; Richard Simon; Lajos Pusztai
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Stacy L Moulder; Frankie A Holmes; Anthony W Tolcher; Peter F Thall; Kristine Broglio; Vicente Valero; Aman U Buzdar; Susan G Arbuck; Andrew D Seidman; Gabriel N Hortobagyi
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frankie Holmes (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Libero Santarpia; Katherine Stemke-Hale; W Fraser Symmans; Vicente Valero; Tatiana Vidaurre; Bailiang Wang; Elliana J Young; Yuan Qi; Daniel J Booser; Giulia Bottai; Angelo Di Leo; Henry Gomez; Ana M Gonzalez-Angulo; Beth Hellerstedt; Frankie A Holmes; Gabriel N Hortobagyi; Joyce O'Shaughnessy; John Pippen; Lajos Pusztai
Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers.
Breast cancer research and treatment 2012;134(1):333-43.
2011: Takayuki Iwamoto; Giampaolo Bianchini; Daniel J Booser; Yuan Qi; Charles Coutant; Christine Ya-Hui Shiang; Libero Santarpia; Junji Matsuoka; Gabriel N Hortobagyi; W Fraser Symmans; Frankie A Holmes; Joyce A O'Shaughnessy; Beth Hellerstedt; John Pippen; Fabrice Andre; Richard Simon; Lajos Pusztai
Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.
Journal of the National Cancer Institute 2011;103(3):264-72.
2010: Stacy L Moulder; Frankie A Holmes; Anthony W Tolcher; Peter F Thall; Kristine Broglio; Vicente Valero; Aman U Buzdar; Susan G Arbuck; Andrew D Seidman; Gabriel N Hortobagyi
A randomized phase 2 trial comparing 3-hour versus 96-hour infusion schedules of paclitaxel for the treatment of metastatic breast cancer.
Cancer 2010;116(4):814-21.
2007: Stephen E Jones; James Cantrell; Svetislava Vukelja; John Pippen; Joyce A O'Shaughnessy; Joanne L Blum; Robert Brooks; Nicole L Hartung; Angel G Negron; Donald A Richards; Ragene Rivera; Frankie A Holmes; Sreeni Chittoor; Thomas L Whittaker; James H Bordelon; Steven J Ketchel; Jennifer C Davis; Des Ilegbodu; Jean Kochis; Lina Asmar
Comparison of menopausal symptoms during the first year of adjuvant therapy with either exemestane or tamoxifen in early breast cancer: report of a Tamoxifen Exemestane Adjuvant Multicenter trial substudy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4765-71.
2007: Garth A Beinart; Ana M Gonzalez-Angulo; Kristine Broglio; Debra Frye; Ronald Walters; Frankie A Holmes; Shivaji Gunale; Daniel J Booser; Julian Rosenthal; Kapil Dhingra; James A Young; Gabriel N Hortobagyi
Phase II trial of 10-EDAM in the treatment of metastatic breast cancer.
Cancer chemotherapy and pharmacology 2007;60(1):61-7.
2007: Yun Gong; Kai Yan; Feng Lin; Keith Anderson; Christos Sotiriou; Fabrice Andre; Frankie A Holmes; Vicente Valero; Daniel J Booser; John Pippen; Svetislava Vukelja; Henry Gomez; Jaime A Mejia, M.D.; Luis J Barajas; Kenneth R Hess; Nour Sneige; Gabriel N Hortobagyi; Lajos Pusztai; W Fraser Symmans
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study.
The lancet oncology 2007;8(3):203-11.
2006: Stephen E Jones; Michael Savin; Frankie A Holmes; Joyce A O'Shaughnessy; Joanne L Blum; Svetislava Vukelja; Kristi J McIntyre; John Pippen; James H Bordelon; Robert Kirby; John Sandbach; William J Hyman; Pankaj Khandelwal; Angel G Negron; Donald A Richards; Stephen P Anthony; Robert G Mennel; Boehm A Kristi; Walter G Meyer; Lina Asmar
Phase III trial comparing doxorubicin plus cyclophosphamide with docetaxel plus cyclophosphamide as adjuvant therapy for operable breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(34):5381-7.
2005: Joyce A O'Shaughnessy; Svetislava Vukelja; Frankie A Holmes; Michael Savin; Monte Jones; Donald Royall; Martine George; Daniel Von Hoff
Feasibility of quantifying the effects of epoetin alfa therapy on cognitive function in women with breast cancer undergoing adjuvant or neoadjuvant chemotherapy.
Clinical breast cancer 2005;5(6):439-46.
2004: Eva Thomas; Frankie A Holmes; Terry L Smith; Aman U Buzdar; Debra Frye; Giuseppe Fraschini; S Eva Singletary; Richard L Theriault; Marsha D McNeese; Frederick C Ames; Ronald Walters; Gabriel N Hortobagyi
The use of alternate, non-cross-resistant adjuvant chemotherapy on the basis of pathologic response to a neoadjuvant doxorubicin-based regimen in women with operable breast cancer: long-term results from a prospective randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(12):2294-302.
2003: Luis A Meza; Michael D Green; James R Hackett; Theresa A Neumann; Frankie A Holmes
Filgrastim-mediated neutrophil recovery in patients with breast cancer treated with docetaxel and doxorubicin.
Pharmacotherapy 2003;23(11):1424-31.
2003: Salvatore Siena; Martine J Piccart; Frankie A Holmes; John Glaspy; James Hackett; Jennifer J Renwick
A combined analysis of two pivotal randomized trials of a single dose of pegfilgrastim per chemotherapy cycle and daily Filgrastim in patients with stage II-IV breast cancer.
Oncology reports 2003;10(3):715-24.
2003: Ernst Kubista; John Glaspy; Frankie A Holmes; Michael D Green; James Hackett; Theresa Neumann
Bone pain associated with once-per-cycle pegfilgrastim is similar to daily filgrastim in patients with breast cancer.
Clinical breast cancer 2003;3(6):391-8.
2002: Frankie A Holmes; Stephen E Jones; Joyce A O'Shaughnessy; Svetislava Vukelja; T George; Michael Savin; D Richards; John Glaspy; Luis A Meza; GARY COHEN; M Dhami; D R Budman; James Hackett; M Brassard; B B Yang; BC Liang
Comparable efficacy and safety profiles of once-per-cycle pegfilgrastim and daily injection filgrastim in chemotherapy-induced neutropenia: a multicenter dose-finding study in women with breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(6):903-9.
2002: Aman U Buzdar; S Eva Singletary; Vicente Valero; Daniel J Booser; Nuhad K Ibrahim; Zia Rahman; Richard L Theriault; Ronald Walters; Edgardo Rivera; Terry L Smith; Frankie A Holmes; Emma Hoy; Debra Frye; Nikki Manuel; Shu-Wan Kau; Marsha D McNeese; Eric A Strom; Eva Thomas; Kelly Hunt; Frederick C Ames; Donald Berry; Gabriel N Hortobagyi
Evaluation of paclitaxel in adjuvant chemotherapy for patients with operable breast cancer: preliminary data of a prospective randomized trial.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(5):1073-9.
2002: Frankie A Holmes; Joyce A O'Shaughnessy; Svetislava Vukelja; Stephen E Jones; J Shogan; Michael Savin; John Glaspy; M Moore; Luis A Meza; I Wiznitzer; Theresa Neumann; L R Hill; BC Liang
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(3):727-31.
2002: Edgardo Rivera; Frankie A Holmes; Aman U Buzdar; Lina Asmar; Shu-Wan Kau; Giuseppe Fraschini; Ronald Walters; Richard L Theriault; Gabriel N Hortobagyi
Fluorouracil, doxorubicin, and cyclophosphamide followed by tamoxifen as adjuvant treatment for patients with stage IV breast cancer with no evidence of disease.
The breast journal 2002;8(1):2-9.
2001: Nuhad K Ibrahim; Vicente Valero; Zia Rahman; Richard L Theriault; Ronald S Walters; Aman U Buzdar; Daniel J Booser; Frankie A Holmes; James L Murray; Jie Willey; Robert C Bast; Gabriel N Hortobagyi
Phase I-II vinorelbine (Navelbine) by continuous infusion in patients with metastatic breast cancer: cumulative toxicities limit dose escalation.
Cancer investigation 2001;19(5):459-66.
2000: Edgardo Rivera; Frankie A Holmes; Debra Frye; Vicente Valero; Richard L Theriault; Daniel J Booser; Ronald Walters; Aman U Buzdar; Kapil Dhingra; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of paclitaxel in patients with metastatic breast carcinoma refractory to standard chemotherapy.
Cancer 2000;89(11):2195-201.
2000: Gabriel N Hortobagyi; Aman U Buzdar; Richard L Theriault; Vicente Valero; Debra Frye; Daniel J Booser; Frankie A Holmes; Sergio Giralt; Issa Khouri; Borje Andersson; James L Gajewski; Gabriela Rondon; T L Smith; S E Singletary; F C Ames; N Sneige; Eric A Strom; Marsha D McNeese; Albert Deisseroth; Richard E Champlin
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma.
Journal of the National Cancer Institute 2000;92(3):225-33.
2000: Daniel J Booser; Ronald S Walters; Frankie A Holmes; Gabriel N Hortobagyi
Continuous-infusion high-dose leucovorin with 5-fluorouracil and cisplatin for relapsed metastatic breast cancer: a phase II study.
American journal of clinical oncology 2000;23(1):40-1.
2000: Francisco J Esteva; L T Soh; Frankie A Holmes; William Plunkett; Christina A Meyers; Arthur Forman; Gabriel N Hortobagyi
Phase II trial and pharmacokinetic evaluation of cytosine arabinoside for leptomeningeal metastases from breast cancer.
Cancer chemotherapy and pharmacology 2000;46(5):382-6.
1999: Beth S Edeiken; Bruno D Fornage; Deepak G Bedi; S Eva Singletary; Nuhad K Ibrahim; Eric A Strom; Frankie A Holmes
US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy.
Radiology 1999;213(3):895-900.
1999: M Cristofanilli; Frankie A Holmes; L Esparza; V Valero; Aman U Buzdar; J A Neidhart; Gabriel N Hortobagyi
Phase I/II trial of high dose mitoxantrone in metastatic breast cancer: the M.D. Anderson Cancer Center experience.
Breast cancer research and treatment 1999;54(3):225-33.
1999: Frankie A Holmes; Vicente Valero; Ronald S Walters; Richard L Theriault; Daniel J Booser; H Gibbs; Giuseppe Fraschini; Aman U Buzdar; Jie Willey; Debra Frye; Lina Asmar; Gabriel N Hortobagyi
Paclitaxel by 24-hour infusion with doxorubicin by 48-hour infusion as initial therapy for metastatic breast cancer: phase I results.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(4):403-11.
1999: D L Berry; Richard L Theriault; Frankie A Holmes; Valerie Parisi; Daniel J Booser; S Eva Singletary; Aman U Buzdar; Gabriel N Hortobagyi
Management of breast cancer during pregnancy using a standardized protocol.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):855-61.
1999: L Pusztai; Frankie A Holmes; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of mitoxantrone by 14-day continuous infusion with granulocyte colony-stimulating factor (GCSF) support in patients with metastatic breast cancer and limited prior therapy.
Cancer chemotherapy and pharmacology 1999;43(1):86-91.
1998: Zia Rahman; John Kavanagh; Richard Champlin; R Giles; EG Hanania; S Fu; Z Zu; RC Mehra; Frankie A Holmes; Andrzej P Kudelka; David F Claxton; Claire F Verschraegen; James L Gajewski; Michael Andreeff; S Heimfeld; R Berenson; D Ellerson; L Calvert; Eugene Mechetner; Tatyana A Holzmayer; A Dayne; J Hamer; CR Bachier; J Ostrove; Albert Deisseroth
Chemotherapy immediately following autologous stem-cell transplantation in patients with advanced breast cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2717-21.
1998: Vicente Valero; Stephen E Jones; Daniel Von Hoff; Daniel J Booser; Robert G Mennel; Peter M Ravdin; Frankie A Holmes; Zia Rahman; M W Schottstaedt; J K Erban; Laura Guerra; R H Earhart; Gabriel N Hortobagyi; Howard A Burris
A phase II study of docetaxel in patients with paclitaxel-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(10):3362-8.
1998: Ronald S Walters; Frankie A Holmes; Vicente Valero; Laura Guerra; Gabriel N Hortobagyi
Phase II study of ifosfamide and mesna in patients with metastatic breast cancer.
American journal of clinical oncology 1998;21(4):413-5.
1997: Frankie A Holmes; A Lopez; Giora Mavligit; Giuseppe Fraschini; Debra Frye; Gabriel N Hortobagyi
Secondary drug resistance in breast cancer: failure to reverse with oral nifedipine.
International journal of cancer. Journal international du cancer 1997;73(2):184-6.
1997: Gabriel N Hortobagyi; Jie Willey; Zia Rahman; Frankie A Holmes; Richard L Theriault; Aman U Buzdar
Prospective assessment of cardiac toxicity during a randomized phase II trial of doxorubicin and paclitaxel in metastatic breast cancer.
Seminars in oncology 1997;24(5 Suppl 17):S17-65-S17-68.
1997: Gabriel N Hortobagyi; Frankie A Holmes; Richard L Theriault; Zia Rahman; Aman U Buzdar
Combination chemotherapy with paclitaxel and doxorubicin for metastatic breast cancer.
Seminars in oncology 1997;24(4 Suppl 11):S11-13-S11-19.
1997: Gabriel N Hortobagyi; Frankie A Holmes; N Ibrahim; Richard Champlin; Aman U Buzdar
The University of Texas M.D. Anderson Cancer Center experience with paclitaxel in breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S30-3.
1997: Gabriel N Hortobagyi; Frankie A Holmes
Optimal dosing of paclitaxel and doxorubicin in metastatic breast cancer.
Seminars in oncology 1997;24(1 Suppl 3):S4-7.
1997: Naoto T Ueno; Aman U Buzdar; S E Singletary; F C Ames; Marsha D McNeese; Frankie A Holmes; Richard L Theriault; Eric A Strom; BJ Wasaff; Lina Asmar; Debra Frye; Gabriel N Hortobagyi
Combined-modality treatment of inflammatory breast carcinoma: twenty years of experience at M. D. Anderson Cancer Center.
Cancer chemotherapy and pharmacology 1997;40(4):321-9.
1997: P M Hoff; Vicente Valero; Frankie A Holmes; H Whealin; Clifford Hudis; G N Hortobagyi
Paclitaxel-induced pancreatitis: a case report.
Journal of the National Cancer Institute 1997;89(1):91-3.
1996: E G Hanania; R E Giles; John Kavanagh; SQ Fu; D Ellerson; Z Zu; T Wang; Y Su; Andrzej P Kudelka; Zia Rahman; Frankie A Holmes; Gabriel N Hortobagyi; David F Claxton; CR Bachier; Peter F Thall; S Cheng; Jeane Hester; J M Ostrove; R E Bird; A Chang; Martin Korbling; D Seong; Richard J Cote; Tatyana A Holzmayer; Albert Deisseroth
Results of MDR-1 vector modification trial indicate that granulocyte/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(26):15346-51.
1996: Frankie A Holmes
Paclitaxel combination therapy in the treatment of metastatic breast cancer.
Seminars in oncology 1996;23(5 Suppl 12):29-39.
1996: Frankie A Holmes
Paclitaxel combination therapy in the treatment of metastatic breast cancer: a review.
Seminars in oncology 1996;23(5 Suppl 11):46-56.
1996: Frankie A Holmes; Timothy Madden; Robert A Newman; Vicente Valero; Richard L Theriault; Giuseppe Fraschini; Ronald S Walters; Daniel J Booser; Aman U Buzdar; Jie Willey; Gabriel N Hortobagyi
Sequence-dependent alteration of doxorubicin pharmacokinetics by paclitaxel in a phase I study of paclitaxel and doxorubicin in patients with metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(10):2713-21.
1996: J Y Payne; Frankie A Holmes; Philip R Cohen; Robert Gagel; Aman U Buzdar; Kapil Dhingra
Paclitaxel: severe mucocutaneous toxicity in a patient with hyperbilirubinemia.
Southern medical journal 1996;89(5):542-5.
1996: Albert Deisseroth; Frankie A Holmes; Gabriel N Hortobagyi; Richard Champlin
Use of safety-modified retroviruses to introduce chemotherapy resistance sequences into normal hematopoietic cells for chemoprotection during the therapy of breast cancer: a pilot trial.
Human gene therapy 1996;7(3):401-16.
1996: Gabriel N Hortobagyi; Frankie A Holmes
Single-agent paclitaxel for the treatment of breast cancer: an overview.
Seminars in oncology 1996;23(1 Suppl 1):4-9.
1996: Richard L Theriault; Ronald S Walters; Frankie A Holmes; Laura Guerra; C Kowal; Gabriel N Hortobagyi
A phase II study of CI-973 [SP-4-3(R)]-1,1-cyclobutane-dicarboxylato (2-)] (2-methyl-1,4-butanediamine-N, N') platinum in patients with refractory advanced breast cancer.
Cancer chemotherapy and pharmacology 1996;38(3):289-91.
1996: K Hoffman; Frankie A Holmes; Giuseppe Fraschini; L Esparza; Debra Frye; Martin N Raber; Robert A Newman; Gabriel N Hortobagyi
Phase I-II study: triciribine (tricyclic nucleoside phosphate) for metastatic breast cancer.
Cancer chemotherapy and pharmacology 1996;37(3):254-8.
1995: Vicente Valero; Frankie A Holmes; Ronald S Walters; Richard L Theriault; L Esparza; Giuseppe Fraschini; G A Fonseca; R E Bellet; Aman U Buzdar; Gabriel N Hortobagyi
Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(12):2886-94.
1995: Frankie A Holmes
Update: the M.D. Anderson Cancer Center experience with paclitaxel in the management of breast carcinoma.
Seminars in oncology 1995;22(4 Suppl 8):9-15.
1995: Aman U Buzdar; Frankie A Holmes; Gabriel N Hortobagyi
Paclitaxel in the treatment of metastatic breast cancer: M.D. Anderson Cancer Center experience.
Seminars in oncology 1995;22(3 Suppl 6):101-4.
1994: Ronald S Walters; Richard L Theriault; Frankie A Holmes; L Esparza; G N Hortobagyi
Phase II study of recombinant alpha-interferon and recombinant interleukin-2 metastatic breast cancer.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1994;16(4):303-5.
1994: Gabriel N Hortobagyi; Frankie A Holmes; R L Theriault; Aman U Buzdar
Use of Taxol (paclitaxel) in breast cancer.
Oncology 1994;51 Suppl 1():29-32.
1994: Aman U Buzdar; S Kau; Gabriel N Hortobagyi; Richard L Theriault; Daniel J Booser; Frankie A Holmes; R Walters; I H Krakoff
Phase I trial of droloxifene in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1994;33(4):313-6.
1994: Aman U Buzdar; Gabriel N Hortobagyi; Debra Frye; D Ho; Daniel J Booser; Vicente Valero; Frankie A Holmes; B K Birmingham; K Bui; C Yeh
Bioequivalence of 20-mg once-daily tamoxifen relative to 10-mg twice-daily tamoxifen regimens for breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(1):50-4.
1994: Kapil Dhingra; Vicente Valero; L Gutierrez; Richard L Theriault; Daniel J Booser; Frankie A Holmes; Aman U Buzdar; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II study of deoxyspergualin in metastatic breast cancer.
Investigational new drugs 1994;12(3):235-41.
1994: Frankie A Holmes
Combination chemotherapy with Taxol (paclitaxel) in metastatic breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5 Suppl 6():S23-7.
1993: Richard L Theriault; Giuseppe Fraschini; Frankie A Holmes; Debra Frye; Jordan U Gutterman; Gabriel N Hortobagyi
The myeloprotective effect of recombinant human granulocyte-macrophage colony-stimulating factor given sequentially with continuous infusion vinblastine in metastatic breast cancer patients.
American journal of clinical oncology 1993;16(2):132-6.
1993: Albert Deisseroth; E G Hanania; S Fu; David F Claxton; Michael Andreeff; Richard Champlin; John Kavanagh; Gabriel N Hortobagyi; Frankie A Holmes; C Reading
Genetic therapy of human neoplastic disease.
Journal of hematotherapy 1993;2(3):373-5.
1993: Frankie A Holmes; Vicente Valero; Ronald S Walters; Richard L Theriault; Daniel J Booser; Giuseppe Fraschini; A U Buzdar; Debra Frye; H R Gibbs; G N Hortobagyi
The M. D. Anderson Cancer Center experience with Taxol in metastatic breast cancer.
Journal of the National Cancer Institute. Monographs 1993;(15):161-9.
1992: Aman U Buzdar; Gabriel N Hortobagyi; S W Kau; Terry L Smith; Giuseppe Fraschini; Frankie A Holmes; Jordan U Gutterman; V M Hug; S Eva Singletary; Frederick C Ames
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(10):1540-6.
1992: Ronald S Walters; Richard L Theriault; Frankie A Holmes; Gabriel N Hortobagyi; L Esparza
Phase II trial of fazarabine (ARA-AC, arabinosyl-5-azacytosine) in metastatic breast cancer.
Investigational new drugs 1992;10(1):43-4.
1992: Ronald S Walters; Debra Frye; Aman U Buzdar; Frankie A Holmes; Gabriel N Hortobagyi
A randomized trial of two dosage schedules of mitomycin C in advanced breast carcinoma.
Cancer 1992;69(2):476-81.
1992: Aman U Buzdar; S W Kau; Gabriel N Hortobagyi; Frederick C Ames; Frankie A Holmes; Giuseppe Fraschini; V Hug; Richard L Theriault; Marsha D McNeese; S Eva Singletary
Clinical course of patients with breast cancer with ten or more positive nodes who were treated with doxorubicin-containing adjuvant therapy.
Cancer 1992;69(2):448-52.
1991: Frankie A Holmes; Ronald S Walters; Richard L Theriault; A D Forman; L K Newton; Martin N Raber; Aman U Buzdar; Debra Frye; Gabriel N Hortobagyi
Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer.
Journal of the National Cancer Institute 1991;83(24):1797-805.
1991: Giuseppe Fraschini; Frankie A Holmes; L Esparza; Richard L Theriault; Aman U Buzdar; Gabriel N Hortobagyi
Phase I-II study of high-dose etoposide in patients with refractory breast cancer.
Investigational new drugs 1991;9(4):365-7.
1991: SD Huan; JC Yau; Frank Dunphy; R O Wallerstein; K Dicke; V Spencer; Charles F LeMaistre; Albert Deisseroth; Gabriel N Hortobagyi; Frankie A Holmes
Impact of autologous bone marrow infusion on hematopoietic recovery after high-dose cyclophosphamide, etoposide, and cisplatin.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(9):1609-17.
1991: J E Macheledt; Aman U Buzdar; Gabriel N Hortobagyi; Debra Frye; J U Gutterman; Frankie A Holmes
Phase II evaluation of interferon added to tamoxifen in the treatment of metastatic breast cancer.
Breast cancer research and treatment 1991;18(3):165-70.
1991: Giuseppe Fraschini; A Ciociola; L Esparza; D Templeton; Frankie A Holmes; Ronald S Walters; Gabriel N Hortobagyi
Evaluation of three oral dosages of ondansetron in the prevention of nausea and emesis associated with cyclophosphamide-doxorubicin chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1991;9(7):1268-74.
1990: R Wallerstein; G Spitzer; Frank Dunphy; SD Huan; Gabriel N Hortobagyi; JC Yau; Aman U Buzdar; Frankie A Holmes; Richard L Theriault; Michael S Ewer
A phase II study of mitoxantrone, etoposide, and thiotepa with autologous marrow support for patients with relapsed breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(11):1782-8.
1990: Frank Dunphy; G Spitzer; Aman U Buzdar; Gabriel N Hortobagyi; L J Horwitz; JC Yau; J A Spinolo; Sundar Jagannath; Frankie A Holmes; R O Wallerstein
Treatment of estrogen receptor-negative or hormonally refractory breast cancer with double high-dose chemotherapy intensification and bone marrow support.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(7):1207-16.
1990: Frankie A Holmes; Herbert A Fritsche; J W Loewy; A M Geitner; R C Sutton; Aman U Buzdar; Gabriel N Hortobagyi
Measurement of estrogen and progesterone receptors in human breast tumors: enzyme immunoassay versus binding assay.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1025-35.
1990: Aman U Buzdar; Marsha D McNeese; Gabriel N Hortobagyi; Terry L Smith; S Kau; Giuseppe Fraschini; V Hug; N Ellerbroek; Frankie A Holmes; Frederick C Ames
Is chemotherapy effective in reducing the local failure rate in patients with operable breast cancer?
Cancer 1990;65(3):394-9.
1990: Gerald P Bodey; V Fainstein; Linda S Elting; E Anaissie; Kenneth Rolston; Nancy Khardori; Andrew Lamb; Carl Plager; WK Murphy; Frankie A Holmes
Beta-lactam regimens for the febrile neutropenic patient.
Cancer 1990;65(1):9-16.
1990: Aman U Buzdar; Gabriel N Hortobagyi; L T Esparza; Frankie A Holmes; J S Ro; Giuseppe Fraschini; B Lichtiger
Elliptinium acetate in metastatic breast cancer--a phase II study.
Oncology 1990;47(2):101-4.
1990: E H Koh; Aman U Buzdar; Frederick C Ames; S Eva Singletary; Marsha D McNeese; Debra Frye; Frankie A Holmes; Giuseppe Fraschini; V Hug; Richard L Theriault
Inflammatory carcinoma of the breast: results of a combined-modality approach--M.D. Anderson Cancer Center experience.
Cancer chemotherapy and pharmacology 1990;27(2):94-100.
1990: P Y Holoye; D G Jeffries; H M Dhingra; Frankie A Holmes; Martin N Raber; M S Engineer; Robert A Newman
Intrapleural etoposide for malignant effusion.
Cancer chemotherapy and pharmacology 1990;26(2):147-50.
1989: E Haron; Kenneth V I Rolston; C Cunningham; Frankie A Holmes; T Umsawasdi; Gerald P Bodey
Oral ciprofloxacin therapy for infections in cancer patients.
The Journal of antimicrobial chemotherapy 1989;24(6):955-62.
1989: R Fleck; Marsha D McNeese; N A Ellerbroek; T A Hunter; Frankie A Holmes
Consequences of breast irradiation in patients with pre-existing collagen vascular diseases.
International journal of radiation oncology, biology, physics 1989;17(4):829-33.
1989: Gabriel N Hortobagyi; V Hug; Aman U Buzdar; S W Kau; Frankie A Holmes; H A Fritsche
Sequential cyclic combined hormonal therapy for metastatic breast cancer.
Cancer 1989;64(5):1002-6.
1989: K Jabboury; Frankie A Holmes; Gabriel N Hortobagyi
5-Fluorouracil rechallenge by protracted infusion in refractory breast cancer.
Cancer 1989;64(4):793-7.
1989: K Jabboury; Debra Frye; Frankie A Holmes; Giuseppe Fraschini; Gabriel N Hortobagyi
Phase II evaluation of gallium nitrate by continuous infusion in breast cancer.
Investigational new drugs 1989;7(2-3):225-9.
1988: Gabriel N Hortobagyi; Frederick C Ames; Aman U Buzdar; S W Kau; Marsha D McNeese; D Paulus; V Hug; Frankie A Holmes; MM Romsdahl; Giuseppe Fraschini
Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy.
Cancer 1988;62(12):2507-16.
1988: Richard L Theriault; Gabriel N Hortobagyi; S W Kau; Frankie A Holmes; V Hug; Giuseppe Fraschini; K Jabboury; Aman U Buzdar
Sequential multiagent chemotherapy incorporating cisplatin, doxorubicin, and cyclophosphamide in the treatment of metastatic breast cancer.
Cancer 1988;62(10):2105-10.
1988: Aman U Buzdar; Gabriel N Hortobagyi; Terry L Smith; S Kau; C Marcus; Frankie A Holmes; V Hug; Giuseppe Fraschini; Frederick C Ames; R G Martin
Adjuvant therapy of breast cancer with or without additional treatment with alternate drugs.
Cancer 1988;62(10):2098-104.
1988: Giuseppe Fraschini; Frankie A Holmes; Aman U Buzdar; V Hug; Gabriel N Hortobagyi
Cisplatin in combination with continuous infusion vinblastine for refractory breast cancer.
American journal of clinical oncology 1988;11(4):448-50.
1988: Aman U Buzdar; C Marcus; Frankie A Holmes; V Hug; Gabriel N Hortobagyi
Phase II evaluation of Ly156758 in metastatic breast cancer.
Oncology 1988;45(5):344-5.
1987: Gabriel N Hortobagyi; Debra Frye; Frankie A Holmes; V Hug; Giuseppe Fraschini; A U Buzdar
Phase II study of iproplatin in metastatic breast carcinoma.
Cancer treatment reports 1987;71(12):1193-6.
1987: Giuseppe Fraschini; F Recchia; Frankie A Holmes
Syndrome of inappropriate antidiuretic hormone secretion associated with hepatic arterial infusion of vinblastine in three patients with breast cancer.
Tumori 1987;73(5):513-6.
1987: Frankie A Holmes; H Y Yap; L Esparza; Aman U Buzdar; G R Blumenschein; V Hug; G N Hortobagyi
Mitoxantrone, cyclophosphamide, and fluorouracil in metastatic breast cancer unresponsive to hormonal therapy.
Cancer 1987;59(12):1992-9.
1987: Giuseppe Fraschini; J Jadeja; M Lawson; Frankie A Holmes; H C Carrasco; S Wallace
Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(4):672-8.
1986: Frankie A Holmes; L Esparza; H Y Yap; Aman U Buzdar; G R Blumenschein; G N Hortobagyi
A comparative study of bisantrene given by two dose schedules in patients with metastatic breast cancer.
Cancer chemotherapy and pharmacology 1986;18(2):157-61.
1984: Frankie A Holmes; H Y Yap; L Esparza; Aman U Buzdar; G N Hortobagyi; G R Blumenschein
Mitoxantrone, cyclophosphamide, and 5-fluorouracil in the treatment of hormonally unresponsive metastatic breast cancer.
Seminars in oncology 1984;11(3 Suppl 1):28-31.